跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Acresil 300 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Acresil 300
Approved
STANDARD
Acresil 300
Flamingo Pharmaceuticals Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
ab462c7ee2b0ce30
Company
Flamingo Pharmaceuticals Ltd.
Type
Standard
Approval Details
Approval Id
ab462c7ee2b0ce30
Drug Approval Philippines Name
Acresil 300
Product Name
Acresil 300
Registration Number
DRP-546
Brand Name
Acresil 300
Generic Name
Clindamycin (As Hydrochloride)
Dosage Form
Capsule
Dosage Strength
300 mg
Manufacturer
Flamingo Pharmaceuticals Ltd.
Importer
Hexagon Pharmaceuticals
Distributor
Hexagon Pharmaceuticals
Issuance Date
28 September 2022
Expiry Date
29 November 2027
Pharmacologic Category
Antibacterial (Lincosamide)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
ab462c7ee2b0ce30
Type
Standard
Back to Philippines FDA Approvals